# T3D Therapeutics, Inc.: Form D filings

T3D Therapeutics, Inc., a pharmaceuticals company in Research Triangle Park, NC, filed 8 Form D notices with the SEC between 2013 and 2022. The latest, on September 6, 2022, reports $6 million sold of a $7.5 million offering to 23 investors.

Find out what T3D Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20T3D%20Therapeutics%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=T3D%20Therapeutics%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Ft3d-therapeutics-inc-1579600)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20T3D%20Therapeutics%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=T3D%20Therapeutics%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Ft3d-therapeutics-inc-1579600)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in North Carolina](https://specstream.ai/data/form-d/state/north-carolina): 984 rows, by operating companies, filed since November 1, 2024, $49.20, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/north-carolina
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 68 T.W. Alexander Drive, Research Triangle Park, NC, 27709
- Phone: (919) 949-0517
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1579600

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sep 6, 2022 | New notice | $7,500,000 | $6,002,712 | $1,497,288 | 23 | Aug 26, 2022 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1579600/000157960022000001/0001579600-22-000001-index.htm) |
| Nov 1, 2019 | New notice | $15,000,000 | $15,000,000 | $0 | 1 | Oct 25, 2019 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1579600/000157960019000001/0001579600-19-000001-index.htm) |
| Mar 12, 2018 | New notice | $18,000,000 | $6,000,000 | $12,000,000 | 1 | Mar 2, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1579600/000157960018000002/0001579600-18-000002-index.htm) |
| Jan 12, 2018 | New notice | $1,000,000 | $711,270 | $288,730 | 30 | Jan 5, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1579600/000157960018000001/0001579600-18-000001-index.htm) |
| Mar 14, 2016 | Amendment | $3,750,200 | $1,210,206 | $2,539,994 | 18 | Feb 26, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1579600/000157960016000002/0001579600-16-000002-index.htm) |
| Mar 13, 2015 | New notice | $3,000,000 | $115,002 | $2,884,998 | 2 | Feb 26, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1579600/000157960015000001/0001579600-15-000001-index.htm) |
| Mar 14, 2014 | New notice | $2,500,000 | $660,997 | $1,839,003 | 9 | Mar 1, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1579600/000157960014000001/0001579600-14-000001-index.htm) |
| Aug 5, 2013 | New notice | $550,000 | $437,000 | $113,000 | 17 | Jun 19, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1579600/000157960013000002/0001579600-13-000002-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Donald Parker | Director |  |
| John Didsbury | Executive Officer, Director, Promoter |  |
| Tom Mendell | Director |  |
| Charles Lineberry | Director |  |
| Barry Buzogany | Director |  |
| John Golden | Director |  |
| David Keim | Director |  |

## Other pharmaceuticals companies in North Carolina that filed recently

- [Dignify Therapeutics, LLC](https://specstream.ai/data/form-d/company/dignify-therapeutics-llc-1622906) $800,000 · Sep 25, 2026

[Every Form D from the week of Sep 5, 2022](https://specstream.ai/data/form-d/week/2022-09-05) · [All recent filings in North Carolina](https://specstream.ai/data/form-d/state/north-carolina) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what T3D Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).